Stratégies thérapeutiques au cours des maladies auto-immunes

Boumpas, 1991, Glucocorticosteroid action on the immune system: molecular and cellular aspects, Clin Exp Rheumatol, 9, 413 Chatenoud, 1994, Use of CD3 antibodies in transplantation and autoimmune diseases, Transplant Proc, 26, 3191 Chen, 1995, Peripheral deletion of antigen-reactive T cells in oral tolerance, Nature, 376, 177, 10.1038/376177a0 Desquenne, 1991, T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis, 88, 7219 Elliott, 1994, Randomized double-bind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis, Lancet, 344, 1105, 10.1016/S0140-6736(94)90628-9 Finck, 1994, Treatment of murine lupus with CTLA4Ig, Science, 265, 1225, 10.1126/science.7520604 Friedman, 1994, Induction of anergy or active suppression following oral tolerance is determined by antigen dosage, 91, 6688 Guery, 1992, Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. Evidence for in vivo MHC-blockade preventing T cell activation, J Exp Med, 175, 1345, 10.1084/jem.175.5.1345 Jameson, 1995, T cell receptor antagonists and partial agonists, Immunity, 2, 1, 10.1016/1074-7613(95)90074-8 Kakimoto, 1988, Isolation of T cell line capable of protecting mice against collagen-induced arthritis, J Immunol, 140, 78, 10.4049/jimmunol.140.1.78 Kavanaugh, 1994, Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1, Arthritis Rheum, 37, 992, 10.1002/art.1780370703 Kazatchkine, 1994, V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (IVIg), Immunol Rev, 139, 79, 10.1111/j.1600-065X.1994.tb00858.x Kunicka, 1993, Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone, Cell Immunol, 149, 39, 10.1006/cimm.1993.1134 Marmont, 1995, Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions, Bone Marrow Transplant, 16, 497 Mor, 1995, Vaccines to prevent and treat autoimmune diseases, Int Arch Allerg Immunol, 108, 345, 10.1159/000237180 Moreland, 1994, Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody, Arthritis Rheum, 37, 834, 10.1002/art.1780370610 Sartor, 1994, Cyclosporine therapy for inflammatory bowel disease, N Engl J Med, 330, 1897, 10.1056/NEJM199406303302612 Scheinman, 1995, Role of transcriptional activation of IkBa in mediation of immunosuppression by glucocorticoids, Science, 270, 283, 10.1126/science.270.5234.283 Schreiber, 1992, The mechanism of action of cyclosporin A and FK506, Immunol Today, 13, 136, 10.1016/0167-5699(92)90111-J Steinberg, 1991, Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only, Arthritis Rheum, 34, 945, 10.1002/art.1780340803 Thompson, 1995, Apoptosis in the pathogenesis and treatment of disease, Science, 267, 1456, 10.1126/science.7878464 Vandenbark, 1989, Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis, Nature, 341, 541, 10.1038/341541a0 Waldmann, 1991, Monoclonal antibodies in diagnosis and therapy, Science, 252, 1657, 10.1126/science.2047874 Weinblatt, 1995, Methotrexate for chronic diseases in adults, N Engl J Med, 333, 330, 10.1056/NEJM199502023320512 Weiner, 1994, Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens, Annu Rev Immunol, 12, 809, 10.1146/annurev.iy.12.040194.004113